AKARI THERAPEUTICS PLC-ADR (AKTX) Stock Balance Sheet
USA - NASDAQ:AKTX - US00972G2075 - ADR
0.5429 USD
-0.05 (-8.22%)
0.55 USD
+0.01 (+1.31%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.71M | 2.60M | 3.85M | 13.25M | 9.36M | |||
| Cash Equivalents | null | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | null | null | null | null | null | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 590.00K | 353.00K | 496.00K | 570.00K | 2.26M | |||
| Total Current Assets | 3.30M | 2.95M | 4.34M | 13.81M | 11.63M | |||
| Non-Current Assets | ||||||||
| PPE Net | null | null | null | null | null | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | 8.43M | 8.43M | null | null | null | |||
| Intangibles | 39.18M | 39.18M | 14.00K | 20.00K | 20.00K | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 47.61M | 47.61M | 14.00K | 20.00K | 20.00K | |||
| TOTAL ASSETS | 50.91M | 50.56M | 4.36M | 13.83M | 11.65M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 1.55M | 3.26M | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 2.47M | 3.14M | 1.57M | 3.15M | 3.18M | |||
| Accounts Payable | 11.61M | 12.41M | 1.67M | 950.00K | 1.79M | |||
| Other Current Liabilities | 1.52M | 1.11M | 1.35M | 7.95M | 1.12M | |||
| Total Current Liabilities | 17.14M | 19.91M | 4.58M | 12.04M | 6.09M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | 8.04M | 8.04M | null | null | null | |||
| Other Non-Current Liabilities | 128.00K | 383.00K | null | null | null | |||
| Total Non-Current Liabilities | 8.17M | 8.42M | 0 | 0 | 0 | |||
| TOTAL LIABILITIES | 25.31M | 28.33M | 4.58M | 12.04M | 6.09M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -200.66M | -195.06M | -175.27M | -165.26M | -147.51M | |||
| Additional Paid In Capital | 220.85M | 212.71M | 174.75M | 167.08M | 153.13M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 6.52M | 5.32M | 1.32M | 740.00K | 480.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -1.11M | -738.00K | -1.04M | -770.00K | -540.00K | |||
| Shares Outstanding | null | null | 6.86M | 3.86M | 2.47M | |||
| Tangible Book Value per Share | -22.005 | -25.381 | 0 | 0.0002 | 0.0012 | |||
| Total Shareholders' Equity | 25.61M | 22.23M | -229.00K | 1.79M | 5.55M | |||
| TOTAL LIABILITIES AND EQUITY | 50.91M | 50.56M | 4.36M | 13.83M | 11.65M | |||
| Statistics | ||||||||
| Current Ratio | 0.19 | 0.15 | 0.95 | 1.15 | 1.91 | |||
| Return On Assets (ROA) | -24.09% | -39.14% | -229.80% | -128.34% | -149.53% | |||
| Return On Equity (ROE) | -47.91% | -89.03% | N/A | -991.62% | -313.87% | |||
All data in USD , ROIC based on taxRate of 0.21